- Home
- ARQT vs RNG Comparison
ARQT vs RNG Comparison
Compare ARQT & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | RNG |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARQT | RNG |
|---|---|---|
| Price | $27.74 | $41.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $34.00 | $33.58 |
| AVG Volume (30 Days) | ★ 1.9M | 1.5M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | 88.79 | ★ 176.19 |
| EPS | N/A | ★ 0.35 |
| Revenue | $376,072,000.00 | ★ $2,515,142,000.00 |
| Revenue This Year | $34.85 | $5.56 |
| Revenue Next Year | $29.39 | $4.56 |
| P/E Ratio | ★ N/A | $116.97 |
| Revenue Growth | ★ 91.34 | 4.78 |
| 52 Week Low | $13.70 | $23.59 |
| 52 Week High | $31.77 | $49.85 |
Technical Indicators
Market Signals| Indicator | ARQT | RNG |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 56.82 |
| Support Level | $22.09 | $37.91 |
| Resistance Level | $28.80 | $43.13 |
| Average True Range (ATR) | 1.24 | 1.87 |
| MACD | 0.07 | 0.60 |
| Stochastic Oscillator | 51.09 | 85.18 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.